YAP1 and gastric cancer: Studies have clearly indicated that the Hippo signaling pathway is abnormally expressed in various solid tumors, including GC, and have suggested that YAP is closely related to tumor growth and metastasis; thus, YAP is a critical therapeutic target in the treatment of GC (95).